Recursion Pharmaceuticals (RXRX) Earnings Date, Estimates & Call Transcripts $5.22 -0.06 (-1.14%) Closing price 04:00 PM EasternExtended Trading$5.24 +0.02 (+0.29%) As of 06:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Recursion Pharmaceuticals Earnings Summary Recursion Pharmaceuticals announced Q1 2025 earnings on May 5, 2025, reporting an EPS of -$0.50, which missed the consensus estimate of -$0.44 by $0.06. Quarterly revenue rose 7.2% year-over-year to $14.75 million, below analysts' expectations of $18.12 million. With a trailing EPS of -$1.77, Recursion Pharmaceuticals' earnings are expected to grow next year, from ($1.57) to ($1.42) per share. Upcoming Q2 Earnings DateAug. 6After Market ClosesEstimatedConsensus EPS (May. 5) -$0.44 Actual EPS (May. 5) -$0.50 Missed By -$0.06 Actual Revenue (May. 5) $14.75MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q) Slide DeckSEC FilingRXRX Upcoming EarningsRecursion Pharmaceuticals' next earnings date is estimated for Wednesday, August 6, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get Recursion Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Recursion Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRXRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RXRX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Recursion Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ2 20251-$0.27-$0.27-$0.27Q3 20251-$0.31-$0.31-$0.31Q4 20251-$0.20-$0.20-$0.20 Recursion Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/6/2025(Estimated)--------5/5/2025Q1 2025-$0.44-$0.50 -$0.06-$0.50$18.12M$14.75M2/28/2025Q4 2024-$0.36-$0.53 -$0.17-$0.53$19.04M$4.60M11/6/2024Q3 2024-$0.33-$0.34 -$0.01-$0.34$12.62M$26.08M8/8/2024Q2 2024-$0.35-$0.40 -$0.05-$0.40$11.96M$14.42M5/9/2024Q1 2024-$0.43-$0.39+$0.04-$0.39$11.10M$13.80M2/27/2024Q4 2023-$0.46-$0.40+$0.06-$0.40$12.37M$10.89M11/9/2023Q3 2023-$0.38-$0.43 -$0.05-$0.43$12.20M$10.53M8/8/2023Q2 2023-$0.38-$0.38--$0.38$10.43M$11.02M Recursion Pharmaceuticals Earnings - Frequently Asked Questions When is Recursion Pharmaceuticals' earnings date? Recursion Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 6th, 2025 based off last year's report dates. Learn more on RXRX's earnings history. Did Recursion Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Recursion Pharmaceuticals (NASDAQ:RXRX) missed the analysts' consensus estimate of ($0.44) by $0.06 with a reported earnings per share (EPS) of ($0.50). Learn more on analysts' earnings estimate vs. RXRX's actual earnings. How can I listen to Recursion Pharmaceuticals' earnings conference call? The conference call for Recursion Pharmaceuticals' latest earnings report can be listened to online. Listen to Conference Call How can I read Recursion Pharmaceuticals' conference call transcript? The conference call transcript for Recursion Pharmaceuticals' latest earnings report can be read online. Read Transcript How can I view Recursion Pharmaceuticals' earnings report? Recursion Pharmaceuticals' earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Recursion Pharmaceuticals generate each year? Recursion Pharmaceuticals (NASDAQ:RXRX) has a recorded annual revenue of $59.82 million. How much profit does Recursion Pharmaceuticals generate each year? Recursion Pharmaceuticals (NASDAQ:RXRX) has a recorded net income of -$463.66 million. RXRX has generated -$1.77 earnings per share over the last four quarters. What is Recursion Pharmaceuticals' EPS forecast for next year? Recursion Pharmaceuticals' earnings are expected to grow from ($1.57) per share to ($1.42) per share in the next year. More Earnings Resources from MarketBeat Related Companies VRNA Earnings Date ROIV Earnings Date ELAN Earnings Date RVMD Earnings Date LEGN Earnings Date GRFS Earnings Date TGTX Earnings Date NUVL Earnings Date LNTH Earnings Date AXSM Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles 3 Analysts Set $600 Target Ahead of Microsoft EarningsTesla: 2 Plays Ahead of Next Week's Earnings ReportFastenal Surges After Earnings Beat, Tariff Risks Loom3 Catalysts Converge on Intel Ahead of a Critical Earnings ReportSmith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still Strong This page (NASDAQ:RXRX) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Recursion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Recursion Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RXRX Stock Alerts